NO20041370L - Nye vannfrie krystallinske former av gabapentin - Google Patents
Nye vannfrie krystallinske former av gabapentinInfo
- Publication number
- NO20041370L NO20041370L NO20041370A NO20041370A NO20041370L NO 20041370 L NO20041370 L NO 20041370L NO 20041370 A NO20041370 A NO 20041370A NO 20041370 A NO20041370 A NO 20041370A NO 20041370 L NO20041370 L NO 20041370L
- Authority
- NO
- Norway
- Prior art keywords
- gabapentin
- crystalline forms
- anhydrous crystalline
- new anhydrous
- new
- Prior art date
Links
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 title 2
- 229960002870 gabapentin Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/38—Separation; Purification; Stabilisation; Use of additives
- C07C227/40—Separation; Purification
- C07C227/42—Crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32837501P | 2001-10-09 | 2001-10-09 | |
| US10/256,155 US6800782B2 (en) | 2001-10-09 | 2002-09-25 | Anhydrous crystalline forms of gabapentin |
| PCT/US2002/031706 WO2003031391A1 (en) | 2001-10-09 | 2002-10-03 | New anhydrous crystalline forms of gabapentin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20041370L true NO20041370L (no) | 2004-04-01 |
Family
ID=26945177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20041370A NO20041370L (no) | 2001-10-09 | 2004-04-01 | Nye vannfrie krystallinske former av gabapentin |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6800782B2 (sr) |
| EP (1) | EP1463712A1 (sr) |
| JP (1) | JP2005505594A (sr) |
| KR (1) | KR20050033525A (sr) |
| CN (1) | CN1568305A (sr) |
| AP (1) | AP2004003025A0 (sr) |
| BG (1) | BG108702A (sr) |
| BR (1) | BR0213156A (sr) |
| CA (1) | CA2462331A1 (sr) |
| CO (1) | CO5570697A2 (sr) |
| CZ (1) | CZ2004416A3 (sr) |
| EA (1) | EA006557B1 (sr) |
| GE (1) | GEP20063936B (sr) |
| HR (1) | HRP20040408A2 (sr) |
| HU (1) | HUP0401782A3 (sr) |
| IL (1) | IL161099A0 (sr) |
| IS (1) | IS7195A (sr) |
| MA (1) | MA27072A1 (sr) |
| MX (1) | MXPA04003301A (sr) |
| NO (1) | NO20041370L (sr) |
| NZ (1) | NZ531993A (sr) |
| OA (1) | OA12665A (sr) |
| PL (1) | PL368117A1 (sr) |
| RS (1) | RS28204A (sr) |
| SK (1) | SK1572004A3 (sr) |
| TN (1) | TNSN04055A1 (sr) |
| WO (1) | WO2003031391A1 (sr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070043236A1 (en) * | 2003-05-19 | 2007-02-22 | Chandiran Thakashina M | Process for preparation of gabapentin |
| WO2004106281A1 (en) * | 2003-05-30 | 2004-12-09 | Ranbaxy Laboratories Limited | Crystalline gabapentin |
| WO2004110342A2 (en) * | 2003-06-12 | 2004-12-23 | Matrix Laboratories Ltd | Novel polymorph of gabapentin and its conversion to gabapentin form-ii |
| US7169812B2 (en) * | 2003-07-01 | 2007-01-30 | Medtronic, Inc. | Process for producing injectable gabapentin compositions |
| ITMI20040579A1 (it) * | 2004-03-25 | 2004-06-25 | Zambon Spa | Processo di preparazione di gabapentina |
| WO2010023694A2 (en) * | 2008-09-01 | 2010-03-04 | Hikal Ltd | Crystalline forms of gabapentin and process thereof |
| CN104649921B (zh) * | 2015-01-14 | 2016-09-28 | 天津大学 | 一种加巴喷丁与己二酸共晶及其制备方法 |
| CN116693410B (zh) * | 2023-06-08 | 2024-06-07 | 浙江竹子制药有限公司 | 一种粒径可控的加巴喷丁制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US4087544A (en) * | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
| JPS62247160A (ja) * | 1986-03-31 | 1987-10-28 | Aisin Seiki Co Ltd | スタ−リングエンジンの始動装置 |
| US4894476A (en) * | 1988-05-02 | 1990-01-16 | Warner-Lambert Company | Gabapentin monohydrate and a process for producing the same |
| US4960931A (en) * | 1988-05-02 | 1990-10-02 | Warner-Lambert Company | Gabapentin mohohydrate and a process for producing the same |
| DE3928184A1 (de) * | 1989-08-25 | 1991-02-28 | Goedecke Ag | Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte |
| IL119890A (en) | 1996-12-24 | 2002-03-10 | Teva Pharma | Gabapentin form iii and preparation of gabapentin form ii |
| ES2137137B1 (es) | 1998-05-25 | 2000-08-16 | Medichem Sa | Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica. |
-
2002
- 2002-09-25 US US10/256,155 patent/US6800782B2/en not_active Expired - Fee Related
- 2002-10-03 EP EP02766485A patent/EP1463712A1/en not_active Withdrawn
- 2002-10-03 HU HU0401782A patent/HUP0401782A3/hu unknown
- 2002-10-03 OA OA1200400095A patent/OA12665A/en unknown
- 2002-10-03 CA CA002462331A patent/CA2462331A1/en not_active Abandoned
- 2002-10-03 CZ CZ2004416A patent/CZ2004416A3/cs unknown
- 2002-10-03 EA EA200400417A patent/EA006557B1/ru not_active IP Right Cessation
- 2002-10-03 AP APAP/P/2004/003025A patent/AP2004003025A0/en unknown
- 2002-10-03 WO PCT/US2002/031706 patent/WO2003031391A1/en not_active Ceased
- 2002-10-03 HR HR20040408A patent/HRP20040408A2/hr not_active Application Discontinuation
- 2002-10-03 JP JP2003534375A patent/JP2005505594A/ja active Pending
- 2002-10-03 BR BR0213156-0A patent/BR0213156A/pt not_active IP Right Cessation
- 2002-10-03 MX MXPA04003301A patent/MXPA04003301A/es active IP Right Grant
- 2002-10-03 KR KR1020047005149A patent/KR20050033525A/ko not_active Ceased
- 2002-10-03 SK SK157-2004A patent/SK1572004A3/sk not_active Application Discontinuation
- 2002-10-03 PL PL02368117A patent/PL368117A1/xx not_active Application Discontinuation
- 2002-10-03 RS YU28204A patent/RS28204A/sr unknown
- 2002-10-03 CN CNA02820056XA patent/CN1568305A/zh active Pending
- 2002-10-03 GE GE5594A patent/GEP20063936B/en unknown
- 2002-10-03 IL IL16109902A patent/IL161099A0/xx unknown
- 2002-10-03 NZ NZ531993A patent/NZ531993A/en unknown
-
2004
- 2004-03-23 IS IS7195A patent/IS7195A/is unknown
- 2004-04-01 NO NO20041370A patent/NO20041370L/no not_active Application Discontinuation
- 2004-04-05 MA MA27606A patent/MA27072A1/fr unknown
- 2004-04-06 CO CO04032599A patent/CO5570697A2/es not_active Application Discontinuation
- 2004-04-07 TN TNP2004000055A patent/TNSN04055A1/fr unknown
- 2004-04-28 BG BG108702A patent/BG108702A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BG108702A (en) | 2005-05-31 |
| HRP20040408A2 (en) | 2004-10-31 |
| GEP20063936B (en) | 2006-10-10 |
| HUP0401782A2 (hu) | 2005-10-28 |
| MXPA04003301A (es) | 2004-07-23 |
| HUP0401782A3 (en) | 2006-01-30 |
| EA200400417A1 (ru) | 2004-10-28 |
| EP1463712A1 (en) | 2004-10-06 |
| IL161099A0 (en) | 2004-08-31 |
| BR0213156A (pt) | 2004-09-14 |
| CO5570697A2 (es) | 2005-10-31 |
| US20030092933A1 (en) | 2003-05-15 |
| RS28204A (sr) | 2006-12-15 |
| CZ2004416A3 (cs) | 2005-03-16 |
| CN1568305A (zh) | 2005-01-19 |
| TNSN04055A1 (fr) | 2006-06-01 |
| PL368117A1 (en) | 2005-03-21 |
| OA12665A (en) | 2006-06-19 |
| KR20050033525A (ko) | 2005-04-12 |
| SK1572004A3 (sk) | 2005-03-04 |
| AP2004003025A0 (en) | 2004-06-30 |
| MA27072A1 (fr) | 2004-12-20 |
| CA2462331A1 (en) | 2003-04-17 |
| US6800782B2 (en) | 2004-10-05 |
| WO2003031391A1 (en) | 2003-04-17 |
| NZ531993A (en) | 2006-09-29 |
| IS7195A (is) | 2004-03-23 |
| JP2005505594A (ja) | 2005-02-24 |
| EA006557B1 (ru) | 2006-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI20021262A0 (fi) | Sokerien kiteytys | |
| EE200300575A (et) | Asitromütsiini kristalsed vormid | |
| CY2015015I1 (el) | Παραγωγη τιακουμυκινης | |
| DK1451192T3 (da) | Ny krystallinsk forbindelse | |
| NO20034308L (no) | Nye tyrokinase-inhibitorer | |
| NO20050072L (no) | Nye inhibitorer av kinaser | |
| NO20035087D0 (no) | Anvendelse av HMG fragment som anti-inflammatoriske midler | |
| ATE369365T1 (de) | Kristallines mikronisat des tiotropiumbromids | |
| NO20043660L (no) | Salter av valsartan | |
| NO20050118D0 (no) | Substituerte fenylsulfonamidinhibitorer av beta-amyolid produksjon | |
| NO20033679L (no) | Nye pyrimidinforbindelser | |
| ITMI20020913A0 (it) | Nuova forma cristallina del cefdinir | |
| ATE430755T1 (de) | Wasserfreies kristallines azidocytosin-hemisulfat-derivat | |
| NO20043595L (no) | Nye kortikosteroider | |
| DK1414824T3 (da) | Nye antikonvulsive derivatsalte | |
| NO20052676D0 (no) | Polymorfer av bicifadin-saltsyre | |
| NO20041370L (no) | Nye vannfrie krystallinske former av gabapentin | |
| NO20041850L (no) | Fremgangsmate for dannelse av profenkrystaller | |
| NO20055657D0 (no) | Nye bioisostaererav aktinonin | |
| NO20041848L (no) | Nye mandelatsalter av substituerte tetracykliske tetrahydrofuranderivater | |
| ITMI20020933A0 (it) | Procedimento per la sintesi di clopidogrel | |
| ITMI20020907A0 (it) | Processo di preparazione della forma amorfa del sale di calcio della atorvastatina | |
| NO20030784L (no) | Forhindring av inkrustasjoner av fosfatholdige dobbeltsalter | |
| ZA200402519B (en) | New anhydrous crystalline forms of gabapentin. | |
| NO20044364L (no) | Hydroksykarbamimidoyl-2-hydroksy-benzensulfonamidderivat-krystaller |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |